Back to Search Start Over

Navigating the Observation Zone: Do Risk Scores Help Stratify Patients With Indeterminate High-Sensitivity Cardiac Troponins?

Authors :
Ashburn NP
McCord JK
Snavely AC
Christenson RH
Apple FS
Nowak RM
Peacock WF
deFilippi CR
Mahler SA
Source :
Circulation [Circulation] 2024 Jan 02; Vol. 149 (1), pp. 70-72. Date of Electronic Publication: 2023 Dec 28.
Publication Year :
2024

Abstract

Competing Interests: Disclosures Dr Ashburn receives funding from the National Heart, Lung, and Blood Institute (T32HL076132). Dr McCord receives research funding and support from Beckman Coulter, Roche Diagnostics, Abbott Laboratories, and Siemens. He is a consultant for Beckman Coulter, Roche Diagnostics, and Siemens. Dr Snavely receives funding from Abbott and Health Resources and Services Administration (1H2ARH399760100). Dr Christenson is a consultant for and receives funding and support from Roche Diagnostics, Siemens Healthineers, Beckman Coulter Diagnostics, Becton Dickinson and Co, Quidel Corp, and Sphingotec GMBH. Dr Apple reports consulting fees from HyTest Ltd., advisory fees from Werfen and Qorvo Biotechnology, nonsalaried grant support through the Hennepin Healthcare Research Institute from Abbott Diagnostics, Abbott POC, Roche Diagnostics, Siemens Healthcare, Quidel, Ortho-Clinical Diagnostics, Becton Dickinson; and fees for serving as Associate Editor for Clinical Chemistry. Dr Peacock received research grants from Brainbox, RCE, and Salix, served as a consultant for Abbott, Brainbox, Instrument Labs, Janssen, Osler, Roche, Siemens, and Vifor, and has stock/ownership interests in AseptiScope Inc, Brainbox Inc, Braincheck Inc, Coagulo Inc, Comprehensive Research Associates LLC, Comprehensive Research Management Inc, Emergencies in Medicine LLC, Fast Inc, Forrest Devices, Ischemia DX LLC, Lucia Inc, Prevencio Inc, RCE Technologies, ROMTech, ScPharma, Trivirum Inc, Upstream Inc. Dr. deFilippi consults for Abbott Diagnostics, Fujirebio, Ortho Diagnostics, Quidell, Roche Diagnostics and Siemens Healthineers. Dr Mahler receives funding and support from Roche Diagnostics, Abbott Laboratories, Ortho Clinical Diagnostics, Siemens, Grifols, Pathfast, OrthoQuidel, Beckman Coulter, Genetesis, Cytovale, Health Resources and Services Administration (1H2ARH399760100) and AHRQ (R01HS029017). He is a consultant for Roche, Quidel, Abbott, Genetesis, Inflammatix, Radiometer, and Amgen and is the Chief Medical Officer for Impathiq Inc.

Details

Language :
English
ISSN :
1524-4539
Volume :
149
Issue :
1
Database :
MEDLINE
Journal :
Circulation
Publication Type :
Academic Journal
Accession number :
38153992
Full Text :
https://doi.org/10.1161/CIRCULATIONAHA.123.065030